Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3073-3076

  Chuang, Yao Yu Eric ^a,b   Chen, Qi ^a   Liber, Howard L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; THYMIDINE KINASE;

ARTICLE; AUTOSOME; CELL LINE; GENE LOCUS; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; IONIZING RADIATION; KNOCKOUT GENE; MUTAGENICITY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS;

EID: 0033168881     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Skopek, T. R., Liber, H. L., Penman, B. W., and Thilly, W. G. Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun., 84: 411-416, 1978.
2. Benjamin, M. B., Potter, H.. Yandell, D. W., and Little, J. B. A system for assaying homologous recombination at the endogenous human thymidine kinase gene. Proc. Natl. Acad. Sci. USA, 88: 6652-6656, 1991.
3. Xia, F., Wang, X., Wang, Y-H., Tsang, N-M., Yandell, D. W., Kelsey, K. T., and Liber, H. L. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closed related human lymphoblast lines. Cancer Res., 55: 12-15, 1995.
4. Little, J., Nagasawa, H., Keng, P., Yu, Y., and Li, C. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem., 270, 11033-11036, 1995.
5. Carrier, F., Smith, M. L., Bae, I., Kilpatrick, K. E., Lansing, T. J., Chen, C-Y., Engelstein, M., Friend, S. H., Henner, W. D., Gilmer, T. M., Kastan, M. B., and Fornace, A. J., Jr. Characterization of human gadd45, a p53-regulated protein. J. Biol. Chem., 269: 32672-32677, 1994.
6. Zhen, W., Denault, C., Loviscek, K., Walter, S., Geng, L., and Vaughan, A. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblasloid cells derived from a common source is primarily determined by their p53 mutational status. Mutat. Res., 346: 85-92, 1995.
7. Amundson, S. A., Xia, F., Wolfson, K., and Liber, H. L. Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mutat. Res., 286: 233-241, 1993.
8. Xia, F., Amundson, S. A., Nickoloff, J. A., and Liber, H. L. Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation. Mol. Cell. Biol., 14: 5850-5857, 1994.
9. Xia, F., and Liber, H. L. The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line. Mutat. Res., 373: 87-97, 1997.
10. Wyllie, A., Carder, P., Clarke, A., Cripps, K., Gledhill, S., Greaves, M., Griffiths, S., Harrison, D., Hooper, M., Morris, R., Purdie C., and Bird, C. Apoptosis in carcinogenesis: the role of p53. Cold Spring Harbor Symp. Quant. Biol., 59: 403-409, 1994.
11. Yu, Y., Li, C-Y., and Little, J. B. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene, 14: 1661-1667, 1997.
12. Mekeel, K. L., Tang, W., Kachnic, L. A., Luo, C. M., DeFrank, J. S., and Powell, S. N. Inactivation of p53 results in high rates of homologous recombination. Oncogene, 14: 1847-1857, 1997.
13. Wolf, D., Harris, N., and Rotter, V. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell, 38: 119-126, 1984.
14. Eliyahu, D., Michalovitz, D., and Oren, M. Overproduction of p53 antigen makes established cells highly tumorigenic. Nature (Lond.), 316: 158-160, 1985.
15. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., and Levine, A. J. Gain of function mutations in p53. Nat. Genet., 4: 42-46, 1993.
16. Iwamoto, K. S., Mizuno, T., Ito, T., Tsuyama, N., Kyoizumi, S., and Seyama, T. Gain-of-function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival. Cancer Res., 56: 3862-3865, 1996.
17. Okaichi, K., Wang, L. H., Ihara, M., and Okumura, Y. Sensitivity to ionizing radiation in Saos-2 cells transfected with mutant p53 genes depends on the mutation position. J. Radiat. Res. (Tokyo), 39: 111-118, 1998.
18. Wang, L. H., Okaichi, K., Ihara, M., and Okumura, Y. Sensitivity of anticancer drugs in saos-2 cells transfected with mutant p53 varied with mutation point. Anticancer Res., 18: 321-325, 1998.
19. Gualberto, A., Aldape, K., Kozakiewicz, K., and Tlsty, T. D. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA, 95: 5166-5171, 1998.
20. Furth, E. E., Thilly, W. G., Penman, B. W., Liber, H. L., and Rand, W. M. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal. Biochem., 110: 1-8, 1981.